Event Listing

Updates on CN and HK patent practices

8Mar

China and Hong Kong has many changes in the last few years on patent practices. For China, the 4th revision of the Chinese Patent Law has passed, introducing patent term adjustment, drug patent term extension, drug patent linkage, partial design, many changes in patent infringement damage determination, and so on. For Hong Kong, the original grant system was introduced. This webinar will cover these and discuss the impact on the best practice.

Audience

All

Speakers

Toby Mak, Tee & Howe

Toby Mak, Tee & Howe

Born and educated in Hong Kong with a PhD in chemistry and The only Chinese patent attorney working in a Beijing Chinese patent firm from Hong Kong.
Past co-chair of the AIPLA’s IP Practice in China committee and current co-chair of the AIPLA’s IP Practice in the Far East committee and is also Vice Chair of the Asian Practice committee of the IPO.

Trained under the UK system and took the UK CIPA examinations, and passed some of the papers. Responsible for publishing articles on China IP update for the UK CIPA Journal.

Member of AIPLA, IPO, UK CIPA and speaks several languages: Chinese (Mandarin and Cantonese), English

Share this page

Shopping Bag (0)

No products in the cart.